KRAS and cancer: In addition to KRAS mutation, KRAS amplification also contribute for disease progression in cancers including PDAC (Silverman et al., 1990; Liu et al., 1998; Heidenblad et al., 2002; O’Hagan et al., 2002; Aguirre et al., 2003; Yamada et al., 2008).